02.03.2013 Views

Target Discovery and Validation Reviews and Protocols

Target Discovery and Validation Reviews and Protocols

Target Discovery and Validation Reviews and Protocols

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Transgenic Models 183<br />

then used to generate chimeric mice. The expression of the marker gene (often<br />

a hybrid containing β-galactosidase <strong>and</strong> neomycin-resistant genes) indicates<br />

that the vector was r<strong>and</strong>omly integrated within a gene. This gene can easily be<br />

identified. Interesting models can be obtained in this way if a correlation can be<br />

established between the expression of the gene trap vector in a given tissue <strong>and</strong><br />

particular health problems in the animals. A series of gene trap vectors have<br />

been designed to identify genes expressed in ES cells or in differentiated tissues,<br />

coding for secreted proteins or activated by specific inducers such as hormones<br />

or growth factors (107–110). Banks of ES cells in which gene trap<br />

vectors have been introduced are available (111).<br />

4. Transgenic Models: Case Studies<br />

Very diverse models of transgenic animals are currently generated.<br />

Established lines of transgenic animals are available as conventional lines, particularly<br />

for transgenic mice used to study some human diseases.<br />

Several databases are available. Information on one database recently launched<br />

can be accessed at http://www.biomedels.net/, http://www.ebi.ac.uk/biomedels,<br />

<strong>and</strong> http://research.bmn.com/mkmdj. Animals are available in The Jackson<br />

Laboratories (Bar Harbor, ME) <strong>and</strong> EMMA (European Mouse Mutant Archive)<br />

as well as in private companies. The number of models is very large <strong>and</strong> some of<br />

them are described in the present review. They have been chosen to exemplify the<br />

potency <strong>and</strong> the flexibility of transgenesis in this field.<br />

4.1. Preparation of Recombinant Proteins<br />

Recombinant proteins are prepared to study their biological properties <strong>and</strong><br />

use as pharmaceuticals. Several production systems are being used or are in<br />

development: bacteria, yeast, animal cells, <strong>and</strong> transgenic plants <strong>and</strong> animals.<br />

Each system offers advantages <strong>and</strong> disadvantages on a case-by-case basis (112).<br />

Milk from transgenic animals is one the most mature systems (2). Before being<br />

transferred to farm animals (rabbits, goats, sheep, pigs, or cows) for the large<br />

production of proteins, gene constructs are evaluated in model transgenic mice.<br />

This approach indicates whether the construct expresses efficiently the transgene<br />

in milk <strong>and</strong> whether the foreign protein in milk in properly posttranscriptionally<br />

modified.<br />

Some recombinant proteins prepared in Chinese hamster ovary (CHO)<br />

cells or in milk of transgenic animals are not properly glycosylated,<br />

γ-carboxylated, or cleaved to generate mature molecules. This limited glycosylation<br />

may be attributable to the low level of maturation enzymes in<br />

producing cells. CHO cells overexpressing some glycosylating enzymes<br />

secrete more completely glycosylated proteins. Transgenic mice overexpressing<br />

the furin gene in their milk can cleave human protein C precursors

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!